I understand we have to be conservative in respect to off take prices etc but why use $537 when we know other companies with worse concentrate are going at $600-$650?? Why not base it on this average figure and then show NPV's based on varying spod prices, currencies etc. Ultinately, this isn't for financing because there's no issues there, it needed to be a sales document. The first thing people look at is the NPV and this low NPV has provided enough ammunition for people to sell down. All of a sudden a $1.20 offer looks acceptable and most would accept, just don't see the logic in using this price. I don't see TG pricing included in this either??
- Forums
- ASX - By Stock
- PLS
- Ann: PFS Outlines Compelling 4MTPA Expansion Option-PLS.AX
Ann: PFS Outlines Compelling 4MTPA Expansion Option-PLS.AX, page-2
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PLS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.57 |
Change
-0.040(1.53%) |
Mkt cap ! $8.672B |
Open | High | Low | Value | Volume |
$2.61 | $2.67 | $2.53 | $99.17M | 38.07M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 3525513 | $2.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.32 | 16925459 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 295865 | 2.660 |
11 | 285796 | 2.650 |
7 | 195605 | 2.640 |
1 | 5000 | 2.630 |
5 | 167434 | 2.620 |
Price($) | Vol. | No. |
---|---|---|
2.670 | 2000 | 1 |
2.680 | 348102 | 3 |
2.690 | 2112 | 3 |
2.700 | 202804 | 12 |
2.710 | 64522 | 10 |
Last trade - 15.59pm 25/11/2024 (20 minute delay) ? |
Featured News
PLS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online